Literature DB >> 35840661

Tutorial: design and execution of CRISPR in vivo screens.

Christian J Braun1,2,3, Andrés Carbonell Adames4, Dieter Saur5,6,7,8, Roland Rad9,10,11,12.   

Abstract

Here we provide a detailed tutorial on CRISPR in vivo screening. Using the mouse as the model organism, we introduce a range of CRISPR tools and applications, delineate general considerations for 'transplantation-based' or 'direct in vivo' screening design, and provide details on technical execution, sequencing readouts, computational analyses and data interpretation. In vivo screens face unique pitfalls and limitations, such as delivery issues or library bottlenecking, which must be counteracted to avoid screening failure or flawed conclusions. A broad variety of in vivo phenotypes can be interrogated such as organ development, hematopoietic lineage decision and evolutionary licensing in oncogenesis. We describe experimental strategies to address various biological questions and provide an outlook on emerging CRISPR applications, such as genetic interaction screening. These technological advances create potent new opportunities to dissect the molecular underpinnings of complex organismal phenotypes.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35840661     DOI: 10.1038/s41596-022-00700-y

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   17.021


  132 in total

1.  A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration.

Authors:  Torsten Wuestefeld; Marina Pesic; Ramona Rudalska; Daniel Dauch; Thomas Longerich; Tae-Won Kang; Tetyana Yevsa; Florian Heinzmann; Lisa Hoenicke; Anja Hohmeyer; Anna Potapova; Ina Rittelmeier; Michael Jarek; Robert Geffers; Maren Scharfe; Frank Klawonn; Peter Schirmacher; Nisar P Malek; Michael Ott; Alfred Nordheim; Arndt Vogel; Michael P Manns; Lars Zender
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 2.  In vivo functional screening for systems-level integrative cancer genomics.

Authors:  Julia Weber; Christian J Braun; Dieter Saur; Roland Rad
Journal:  Nat Rev Cancer       Date:  2020-07-07       Impact factor: 60.716

3.  Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation.

Authors:  Christian J Braun; Peter M Bruno; Max A Horlbeck; Luke A Gilbert; Jonathan S Weissman; Michael T Hemann
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

4.  Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.

Authors:  Sidi Chen; Neville E Sanjana; Kaijie Zheng; Ophir Shalem; Kyungheon Lee; Xi Shi; David A Scott; Jun Song; Jen Q Pan; Ralph Weissleder; Hakho Lee; Feng Zhang; Phillip A Sharp
Journal:  Cell       Date:  2015-03-05       Impact factor: 41.582

5.  DNA damage-mediated induction of a chemoresistant niche.

Authors:  Luke A Gilbert; Michael T Hemann
Journal:  Cell       Date:  2010-10-29       Impact factor: 41.582

Review 6.  Tissue-specific tumorigenesis: context matters.

Authors:  Günter Schneider; Marc Schmidt-Supprian; Roland Rad; Dieter Saur
Journal:  Nat Rev Cancer       Date:  2017-03-03       Impact factor: 60.716

7.  A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.

Authors:  Zoë N Rogers; Christopher D McFarland; Ian P Winters; Santiago Naranjo; Chen-Hua Chuang; Dmitri Petrov; Monte M Winslow
Journal:  Nat Methods       Date:  2017-05-22       Impact factor: 28.547

8.  A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system.

Authors:  Martin W LaFleur; Thao H Nguyen; Matthew A Coxe; Kathleen B Yates; Justin D Trombley; Sarah A Weiss; Flavian D Brown; Jacob E Gillis; Daniel J Coxe; John G Doench; W Nicholas Haining; Arlene H Sharpe
Journal:  Nat Commun       Date:  2019-04-10       Impact factor: 14.919

9.  RNAi screens in mice identify physiological regulators of oncogenic growth.

Authors:  Slobodan Beronja; Peter Janki; Evan Heller; Wen-Hui Lien; Brice E Keyes; Naoki Oshimori; Elaine Fuchs
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

10.  A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses.

Authors:  Eric H Bent; Luke A Gilbert; Michael T Hemann
Journal:  Genes Dev       Date:  2016-08-26       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.